All Hypoxia

Acute cerebral infarction continues to represent a substantial global health burden, driving the ongoing search for novel and effective therapeutic targets to mitigate long-term disability. In a study published in Metabolic Brain Disease, titled “Vitamin D and hypoxia-inducible factors signaling interplay: A hypothesis-driven review of therapeutic strategies for acute cerebral infarction,” Yan and colleagues investigated the interaction between Vitamin D and Hypoxia-inducible factors (HIFs) as a neuroprotective strategy.